Henning Grønbaek

Author PubWeight™ 32.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroenterol 2009 2.79
2 Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C. Hepatology 2014 1.73
3 Effects of five different alcoholic drinks on patients with Crohn's disease. Scand J Gastroenterol 2007 1.51
4 Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2007 1.49
5 Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. Int J Cancer 2010 1.40
6 Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 2007 1.27
7 The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 2009 1.24
8 Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours. Acta Oncol 2010 1.15
9 Soluble CD163 from activated macrophages predicts mortality in acute liver failure. J Hepatol 2007 1.12
10 Development and evaluation of an ELISA for human trefoil factor 3. Clin Chem 2002 0.90
11 Ischemic pre- and postconditioning has pronounced effects on gene expression profiles in the rat liver after ischemia/reperfusion. Am J Physiol Gastrointest Liver Physiol 2012 0.88
12 The insulin-like growth factor (IGF) system and its relation to infliximab treatment in adult patients with Crohn's disease. Scand J Gastroenterol 2007 0.87
13 The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn's disease: relations to disease activity and corticosteroid treatment. Growth Horm IGF Res 2006 0.87
14 Description of patients with midgut carcinoid tumours: clinical database from a Danish centre. In Vivo 2007 0.84
15 Metabolic changes in the pig liver during warm ischemia and reperfusion measured by microdialysis. J Gastrointest Surg 2007 0.83
16 Treatment of ascites and spontaneous bacterial peritonitis - part I. Dan Med J 2012 0.81
17 Discharge diagnoses of liver diseases in Nuuk Greenland compared to a Danish county hospital. Int J Circumpolar Health 2006 0.78
18 Effects of long-acting somatostatin analogues on adrenal growth and phosphoribosyl pyrophosphate formation in experimental diabetes. Int J Exp Pathol 2012 0.78
19 Expression of genes involved in rat liver angiogenesis after ischaemia and reperfusion: effects of ischaemic pre- and post-conditioning. HPB (Oxford) 2010 0.78
20 The IGF system after insertion of a transjugular intrahepatic porto-systemic shunt in patients with liver cirrhosis. Eur J Endocrinol 2009 0.77
21 Insulin-like growth factor binding protein 1 (IGFBP-1) in vaginal fluid in pregnancy. In Vivo 2004 0.77
22 Effect of combination therapy with a calcium channel blocker and an angiotensin-converting enzyme inhibitor on renal hypertrophy and urinary albumin excretion in diabetic rats. Exp Diabesity Res 2004 0.77
23 Opposite effects on regulation of urea synthesis by early and late uraemia in rats. Clin Nutr 2007 0.76
24 Ascites from patients with alcoholic liver cirrhosis contains higher IGF-I bioactivity than serum. Clin Endocrinol (Oxf) 2009 0.76
25 Effects of urodilatin on natriuresis in cirrhosis patients with sodium retention. BMC Gastroenterol 2007 0.76
26 Complement activation capacity in plasma before and during high-dose prednisolone treatment and tapering in exacerbations of Crohn's disease and ulcerative colitis. BMC Gastroenterol 2005 0.76
27 Tumor necrosis factor-alpha acutely up-regulates urea synthesis in vivo in rats--a hepatic component of inflammatory catabolism? Scand J Clin Lab Invest 2010 0.76
28 Circulating mannan-binding lectin, M-, L-, H-ficolin and collectin-liver-1 levels in patients with acute liver failure. Liver Int 2014 0.76
29 Insulin sensitivity and body composition in cirrhosis: changes after TIPS. Am J Physiol Gastrointest Liver Physiol 2010 0.75
30 Effects of long-term experimental diabetes on adrenal gland growth and phosphoribosyl pyrophosphate formation in growth hormone-deficient dwarf rats. Int J Exp Pathol 2012 0.75
31 Body composition changes after transjugular intrahepatic portosystemic shunt in patients with cirrhosis. World J Gastroenterol 2010 0.75
32 Impact of enteral supplements enriched with omega-3 fatty acids and/or omega-6 fatty acids, arginine and ribonucleic acid compounds on leptin levels and nutritional status in active Crohn's disease treated with prednisolone. Digestion 2007 0.75
33 Effects of long-acting somatostatin analogues on redox systems in rat lens in experimental diabetes. Int J Exp Pathol 2014 0.75
34 Reply: To PMID 24623375. Hepatology 2015 0.75
35 Growth hormone and growth hormone secretagogue effects on nitrogen balance and urea synthesis in steroid treated rats. Growth Horm IGF Res 2009 0.75
36 [Therapy of continuously bleeding oesophageal varices by self expanding metal stents]. Ugeskr Laeger 2007 0.75
37 Treatment of the hepatorenal syndrome and hyponatremia in cirrhosis - part II. Dan Med J 2012 0.75
38 Unchanged capacity of urea synthesis during acute phase response in rats. Eur J Clin Invest 2010 0.75
39 Insulin-like growth factors (IGFs) and IGF binding proteins in active Crohn's disease treated with omega-3 or omega-6 fatty acids and corticosteroids. Scand J Gastroenterol 2005 0.75
40 [Treatment of bleeding esophageal varices. A 20-year old research-based successful history--how does it continue?]. Ugeskr Laeger 2007 0.75
41 [Liver biopsy in liver patients with coagulopathy]. Ugeskr Laeger 2008 0.75
42 The influence of amphotericin B and neomycin on the effect of human relaxin-2 on foetal membranes and isolated myometrium. Basic Clin Pharmacol Toxicol 2004 0.75
43 [TIPS--transjugular intrahepatic portosystemic shunt. Experiences from a recently started center]. Ugeskr Laeger 2003 0.75
44 [Key issues for the number of publications by Ph.D. graduates in medicine and pharmaceutical sciences]. Ugeskr Laeger 2009 0.75
45 [Screening for hepatocellular carcinoma?]. Ugeskr Laeger 2009 0.75
46 Chemoembolization of intermediate stage hepatocellular carcinomas: results from a Nordic tertiary liver cancer center. Indian J Gastroenterol 2013 0.75
47 [Nonalcoholic steatohepatitis. Three case reports]. Ugeskr Laeger 2003 0.75